Your browser doesn't support javascript.
loading
[Omalizumab in the treatment of chronic urticaria: what's new in 2013?]. / Allergologie. Omalizumab dans le traitement de l'urticaire chronique: quoi de neuf en 2013 ?
Spoerl, David; Harr, Thomas; Seebach, Jörg D.
Afiliação
  • Spoerl D; Service d'immunologie et d'allergologie, Departement de médecine interne, HUG, 1211 Geneve. david.spoerl@hcuge.ch
  • Harr T; Service d'immunologie et d'allergologie, Departement de médecine interne, HUG, 1211 Geneve.
  • Seebach JD; Service d'immunologie et d'allergologie, Departement de médecine interne, HUG, 1211 Geneve.
Rev Med Suisse ; 10(412-413): 18-23, 2014 Jan 15.
Article em Fr | MEDLINE | ID: mdl-24558892
ABSTRACT
In 2013, new crucial data dealing with the treatment options for chronic idiopathic and physical urticaria have been published. In this article, after a short introduction where we discuss the classification and the pathogenesis of the disease, we will focus on the therapeutic approach in patients with chronic urticaria. In particular, considering the data available on the treatment with omalizumab, we will discuss the indications and treatment modalities of chronic urticaria.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Anticorpos Anti-Idiotípicos / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: Fr Ano de publicação: 2014 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Anticorpos Anti-Idiotípicos / Anticorpos Monoclonais Humanizados Limite: Humans Idioma: Fr Ano de publicação: 2014 Tipo de documento: Article